These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3325296)

  • 1. Elevation of plasma prolactin concentrations by intravenous SCH 23390 and SKF 38393 in conscious rats.
    Tanimoto K; Tamminga CA; Chase TN
    Eur J Pharmacol; 1987 Dec; 144(2):147-51. PubMed ID: 3325296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of D1 dopamine receptors that stimulate prolactin release in the rat pituitary.
    Cocchi D; Ingrassia S; Rusconi L; Villa I; Müller EE
    Eur J Pharmacol; 1987 Oct; 142(3):425-9. PubMed ID: 2962879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-1 dopamine receptor stimulation elevates plasma prolactin levels.
    Saller CF; Salama AI
    Eur J Pharmacol; 1986 Mar; 122(1):139-42. PubMed ID: 3007174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-1 and D-2 dopamine receptor blockade: interactive effects in vitro and in vivo.
    Saller CF; Salama AI
    J Pharmacol Exp Ther; 1986 Mar; 236(3):714-20. PubMed ID: 3005552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine receptor-mediated spinal antinociception in the normal and haloperidol pretreated rat: effects of sulpiride and SCH 23390.
    Barasi S; Ben-Sreti MM; Clatworthy AL; Duggal KN; Gonzalez JP; Robertson J; Rooney KF; Sewell RD
    Br J Pharmacol; 1987 Jan; 90(1):15-22. PubMed ID: 3545350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of SCH 23390, a D-1-selective antagonist, with the anterior pituitary D-2 receptors and prolactin secretion in the rat.
    Apud JA; Masotto C; Ongini E; Racagni G
    Eur J Pharmacol; 1985 Jun; 112(2):187-93. PubMed ID: 2863153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of [3H]SCH 23390 specific binding sites in anterior pituitary: dissociation from effects on prolactin secretion.
    Rovescalli AC; Brunello N; Monopoli A; Ongini E; Racagni G
    Eur J Pharmacol; 1987 Mar; 135(2):129-36. PubMed ID: 3556197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine D1 receptor mediation of the discriminative stimulus properties of SKF 38393.
    Cunningham KA; Callahan PM; Appel JB
    Eur J Pharmacol; 1985 Dec; 119(1-2):121-5. PubMed ID: 2935415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine D1 receptor analogues act centrally to stimulate prolactin secretion in ewes.
    Curlewis JD; Clarke IJ; McNeilly AS
    J Endocrinol; 1993 Jun; 137(3):457-64. PubMed ID: 8371076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of locally applied D-1 and D-2 receptor agonists and antagonists studied with brain dialysis.
    Imperato A; Di Chiara G
    Eur J Pharmacol; 1988 Nov; 156(3):385-93. PubMed ID: 2905668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of dopamine D-1 receptors by SKF 38393 induces EEG desynchronization and behavioral arousal.
    Ongini E; Caporali MG; Massotti M
    Life Sci; 1985 Dec; 37(24):2327-33. PubMed ID: 3877855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats.
    Monti JM; Fernández M; Jantos H
    Neuropsychopharmacology; 1990 Jun; 3(3):153-62. PubMed ID: 2141985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute effects of D-1 and D-2 dopamine receptor agonist and antagonist drugs on basal ganglia [Met5]- and [Leu5]-enkephalin and neurotensin content in the rat.
    Taylor MD; de Ceballos ML; Jenner P; Marsden CD
    Biochem Pharmacol; 1991 May; 41(9):1385-91. PubMed ID: 1673340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The D-1 antagonist SCH 23390 stimulates while the D-1 agonist SKF 38393 fails to affect dopamine release in the dorsal caudate of freely moving rats.
    Imperato A; Mulas A; Di Chiara G
    Eur J Pharmacol; 1987 Oct; 142(1):177-81. PubMed ID: 2891544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of dopamine D-2 but not D-1 receptors reduces immobility time of rats in the forced swimming test: implication for antidepressant activity.
    Borsini F; Lecci A; Mancinelli A; D'Aranno V; Meli A
    Eur J Pharmacol; 1988 Apr; 148(3):301-7. PubMed ID: 2968270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the selectivity and specificity of the antagonism of apomorphine-induced suppression of exploration by sulpiride.
    Ståhle L; Ungerstedt U
    Psychopharmacology (Berl); 1989; 99(1):75-9. PubMed ID: 2528780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR; Napier TC; Mueller RA
    J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects induced by chronic treatment with selective D1 or D2 antagonists on open-field behavior and colonic temperature.
    Maldonado R; Baamonde A; Daugé V; Féger J
    Fundam Clin Pharmacol; 1990; 4(3):341-56. PubMed ID: 2142927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.